Creating Living Therapeutics at the Royal Prince Alfred Hospital




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Creating Living Therapeutics at the Royal Prince Alfred Hospital
Released on: August 21, 2017. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who’s needs are currently unmet.
  • Summary
  • Transcript
  • Participants
  • Company
Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who’s needs are currently unmet. John Rasko chats about developing "living therapeutics" with Summer Parks of PharmaVentures at this years ISCT in London.
Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who’s needs are currently unmet. John Rasko chats about developing "living therapeutics" with Summer Parks of PharmaVentures at this years ISCT in London.
John Rasko
Cell and Molecular Therapies (CMT), Royal Prince Alfred Hospital are committed to the development of novel cell therapies and the subsequent improvement in survival and quality of life of patients who’s needs are currently unmet. John Rasko chats about developing "living therapeutics" with Summer Parks of PharmaVentures at this years ISCT in London.